EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Allergen‐Encapsulating Nanoparticles Reprogram Pathogenic Allergen‐Specific Th2 Cells to Suppress Food Allergy

Michael N Saunders iD, Laila M Rad, Laura A Williams, Jeffrey J Landers, Russell R Urie, Sarah E Hocevar, Miguel Quiros, Ming-Yi Chiang, Amogh R Angadi, Katarzyna W Janczak, Elizabeth J Bealer, Kelly Crumley und 9 weitere

Advanced Healthcare Materials · 2025-02 · 14 (5)

DOI: 10.1002/adhm.202400237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 09.05.2024. Verfasst von Michael N Saunders und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA. Hauptthemen laut MEDLINE: Food Hypersensitivity, Th2 Cells, Allergens, Nanoparticles. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Food allergy is a prevalent, potentially deadly disease caused by inadvertent sensitization to benign food antigens. Pathogenic Th2 cells are a major driver for disease, and allergen‐specific immunotherapies (AIT) aim to increase the allergen threshold required to elicit severe allergic symptoms. However, the majority of AIT approaches require lengthy treatments and convey transient disease suppression, likely due to insufficient targeting of pathogenic Th2 responses. Here, the ability of allergen‐encapsulating nanoparticles to directly suppress pathogenic Th2 responses and reactivity is investigated in a mouse model of food allergy. NPs associate with pro‐tolerogenic antigen presenting cells, provoking accumulation of antigen‐specific, functionally suppressive regulatory T cells in the small intestine lamina propria. Two intravenous doses of allergen encapsulated in poly(lactide‐co‐glycolide) nanoparticles (NPs) significantly reduces oral food challenge (OFC)‐induced anaphylaxis. Importantly, NP treatment alters the fates of pathogenic allergen‐specific Th2 cells, reprogramming these cells toward CD25 + FoxP3 + regulatory and CD73 + FR4 + anergic phenotypes. NP‐mediated reductions in the frequency of effector cells in the gut and mast cell degranulation following OFC are also demonstrated. These studies reveal mechanisms by which an allergen‐encapsulating NP therapy and, more broadly, allergen‐specific immunotherapies, can rapidly attenuate allergic responses by targeting pathogenic Th2 cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Food HypersensitivityTh2 CellsAllergensNanoparticlesAnimalsMiceT-Lymphocytes, RegulatoryMice, Inbred BALB CFemaleDisease Models, AnimalPolylactic Acid-Polyglycolic Acid Copolymer

Stichwörter der Autor:innen

allergen‐specific Th2 cellsallergen‐specific immunotherapy mechanismsbiomaterialspolymeric nanoparticlesregulatory T cells

Substanzen

AllergensPolylactic Acid-Polyglycolic Acid Copolymer

Autor:innen und Institutionen

  • Department of Biomedical Engineering, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Mary H. Weiser Food Allergy Center, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Neuroscience Graduate Program, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Department of Pathology, University of Michigan, Ann Arbor, MI, 48109, USA.
  • Department of Microbiology-Immunology, Northwestern University, Chicago, IL, 60611, USA.
  • Center for Human Immunobiology, Northwestern University, Chicago, IL, 60611, USA.

ORCID-Profile: Michael N Saunders, Jessica J O'Konek, Lonnie D Shea

Förderung

  • NIH HHS
  • NIGMS NIH HHS
  • NIAID NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health

Zitieren

APA

Saunders, M. N., Rad, L. M., Williams, L. A., Landers, J. J., Urie, R. R., Hocevar, S. E., Quiros, M., Chiang, M. Y., Angadi, A. R., Janczak, K. W., Bealer, E. J., Crumley, K., Benson, O. E., Griffin, K. V., Ross, B. C., Parkos, C. A., Nusrat, A., Miller, S. D., Podojil, J. R., …, & Shea, L. D. (2025). Allergen‐Encapsulating Nanoparticles Reprogram Pathogenic Allergen‐Specific Th2 Cells to Suppress Food Allergy. Advanced Healthcare Materials, 14(5). https://doi.org/10.1002/adhm.202400237

Vancouver

Saunders MN, Rad LM, Williams LA, Landers JJ, Urie RR, Hocevar SE, et al. Allergen‐Encapsulating Nanoparticles Reprogram Pathogenic Allergen‐Specific Th2 Cells to Suppress Food Allergy. Advanced Healthcare Materials. 2025;14(5). doi:10.1002/adhm.202400237

BibTeX
@article{Saunders2025,
  author = {Saunders, Michael N and Rad, Laila M and Williams, Laura A and Landers, Jeffrey J and Urie, Russell R and Hocevar, Sarah E and Quiros, Miguel and Chiang, Ming-Yi and Angadi, Amogh R and Janczak, Katarzyna W and Bealer, Elizabeth J and Crumley, Kelly and Benson, Olivia E and Griffin, Kate V and Ross, Brian C and Parkos, Charles A and Nusrat, Asma and Miller, Stephen D and Podojil, Joseph R and O'Konek, Jessica J and Shea, Lonnie D},
  title = {Allergen‐Encapsulating Nanoparticles Reprogram Pathogenic Allergen‐Specific Th2 Cells to Suppress Food Allergy},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  volume = {14},
  number = {5},
  doi = {10.1002/adhm.202400237}
}
Kostenlos starten →